Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
The interferon-free combination of the protease inhibitor ABT-450 with ritonavir (ABT-450/r) and the NS5A inhibitor ombitasvir (also known as ABT-267) plus the nonnucleoside polymerase inhibitor dasabuvir (also known as ABT-333) and ribavirin has shown efficacy against the hepatitis C virus (HCV) in...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | 英语 |
| 出版: |
2014
|
| 在线阅读: | https://doi.org/10.1056/nejmoa1315722 https://www.nejm.org/doi/pdf/10.1056/NEJMoa1315722?articleTools=true |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|